Crucell N.V. · Leiden The Netherlands
| Archimedesweg 4-6 | Phone: +31-71-519-91-01 |
| Leiden | Fax: +31-71-519-98-00 |
| 2333 CN | |
| The Netherlands |
Map This Company |
- Company Profiles
- Competitive Landscapes
- Industry Reports
Buy Reports
For a Hoover's Free Trial, Call
(866) 444-8642or
Chat NowCompany Description
Crucell wants to play a crucial role in the fight against deadly diseases. The global biotech firm develops, produces, and markets vaccines and antibodies to prevent and treat infectious diseases. Many of its products are based on its PER.C6 technology platform, and its primary product lines are focused on pediatric, travel, endemic (native to certain regions), and respiratory ailments. Crucell's marketed vaccines fight about a dozen major infectious diseases (including diptheria, hepatitis A and B, influenza, and typhoid) and are offered in more than 100 countries worldwide. The company was acquired by Johnson & Johnson (J&J) in 2011, becoming J&J's primary vaccine unit.

Crucell N.V. Reports

No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.

Top Crucell N.V. Competitors